We are live on ! Find out more
NM

Newtyn Management Portfolio holdings

AUM $936M
1-Year Est. Return 27.23%
This Fund
S&P 500
This Quarter Est. Return
-13.81%
1 Year Est. Return
+27.23%
3 Year Est. Return
+51.99%
5 Year Est. Return
+55.23%
10 Year Est. Return
+165.15%
AUM
$528M
AUM Growth
+$110M
Cap. Flow
+$174M
Cap. Flow %
32.89%
Top 10 Hldgs %
50.68%
Holding
87
New
48
Increased
19
Reduced
11
Closed
3

Top Buys

Rank Stock Value
1
CNNE icon
Cannae Holdings
CNNE
+$29.4M
2
PPLI
People Inc
PPLI
+$28.8M
3
AMBP icon
Ardagh Metal Packaging
AMBP
+$25.5M
4
ONL
Orion Office REIT
ONL
+$15.6M
5
LW icon
Lamb Weston
LW
+$9.91M

Top Sells

Rank Stock Value
1
LYLT
Loyalty Ventures Inc. Common Stock
LYLT
+$9.48M
2
RLJ.PRA icon
RLJ Lodging Trust $1.95 Series A Preferred Stock
RLJ.PRA
+$6.69M
3
PCG icon
PG&E
PCG
+$5.41M
4
TSVT
2seventy bio
TSVT
+$3.28M
5
ASTL icon
Algoma Steel
ASTL
+$2.62M

Sector Composition

Rank Sector Weight
1 Healthcare 23.3%
2 Consumer Discretionary 16.93%
3 Financials 13.63%
4 Real Estate 8.52%
5 Technology 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WGS icon
51
GeneDx Holdings
WGS
$1.93B
$1.44M 0.27%
34,697
+16,515
+91% +$1.12M
IVVD icon
52
Invivyd
IVVD
$158M
$1.31M 0.25%
+400,875
New +$1.26M
WVE icon
53
Wave Life Sciences
WVE
$1.09B
$1.31M 0.25%
+403,553
New +$776K
DBTX
54
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$1.3M 0.25%
+310,000
New +$732K
BDTX icon
55
Black Diamond Therapeutics
BDTX
$96.8M
$1.28M 0.24%
+520,000
New +$1.21M
ADVM
56
DELISTED
Adverum Biotechnologies
ADVM
$1.24M 0.24%
+103,500
New +$1.08M
ALGS icon
57
Aligos Therapeutics
ALGS
$26.2M
$1.16M 0.22%
+38,484
New +$1.31M
IOVA icon
58
Iovance Biotherapeutics
IOVA
$1.82B
$1.16M 0.22%
+105,000
New +$1.38M
ALEC icon
59
Alector
ALEC
$168M
$1.07M 0.2%
+105,000
New +$1.05M
ETNB
60
DELISTED
89bio
ETNB
$998K 0.19%
+310,000
New +$936K
EAR
61
DELISTED
Eargo, Inc. Common Stock
EAR
$987K 0.19%
65,603
-31,897
-33% -$1.51M
FTH
62
Faeth Therapeutics
FTH
$702M
$942K 0.18%
+20,750
New +$778K
AMR icon
63
Alpha Metallurgical Resources
AMR
$1.74B
$816K 0.15%
6,319
– –
TCRX icon
64
TScan Therapeutics
TCRX
$48.6M
$782K 0.15%
+248,611
New +$680K
HTT
65
High Templar Tech Ltd
HTT
$379M
$759K 0.14%
+690,290
New +$673K
NUVB icon
66
Nuvation Bio
NUVB
$2.2B
$680K 0.13%
+210,000
New +$916K
ORIC icon
67
Oric Pharmaceuticals
ORIC
$1.15B
$672K 0.13%
+150,000
New +$598K
RFL icon
68
Rafael Holdings
RFL
$101M
$561K 0.11%
304,200
-100,298
-25% -$200K
SIOX
69
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$510K 0.1%
+1,415,859
New +$586K
KRON
70
DELISTED
Kronos Bio
KRON
$461K 0.09%
+126,623
New +$574K
DOMA
71
DELISTED
Doma Holdings, Inc.
DOMA
$309K 0.06%
+12,000
New +$510K
TLIS
72
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$231K 0.04%
+18,982
New +$300K
AMYT
73
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$207K 0.04%
+29,656
New +$231K
BCAB icon
74
BioAtla
BCAB
$5.46M
$186K 0.04%
+1,307
New +$208K
LAXXR
75
DELISTED
8i Acquisition 2 Corp Rights
LAXXR
$173K 0.03%
+750,000
New +$216K
1 2
3
4

Similar funds

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PWAM
Private Wealth Asset Management Cedar Rapids, Iowa $935M AUM 17.66% 1-Year Est. Return
NI
NetEase Inc Hangzhou, China $934M AUM 11.31% 1-Year Est. Return
MCM
Massar Capital Management Stamford, Connecticut $934M AUM 14.18% 1-Year Est. Return
TS
Tamar Securities Woodland Hills, California $934M AUM 26.74% 1-Year Est. Return
TW
TritonPoint Wealth Chevy Chase, Maryland $934M AUM 23.95% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
FPI
Financial Plan Inc Bellingham, Washington $933M AUM

Newtyn Management's Q2 2022 Portfolio in Review

As of Q2 2022, Newtyn Management held 87 positions worth $528M, up 26% from $418M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Newtyn Management deployed $174M of net new capital in Q2 2022, opening 48 new positions and adding to 19 existing holdings. Its largest new stake was Cannae Holdings: 1,400,000 shares worth $27.1M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was RLJ Lodging Trust $1.95 Series A Preferred Stock, an estimated $6.69M trimmed.

  • Newtyn Management's largest Q2 2022 buy was Cannae Holdings: 1,400,000 shares worth $27.1M.
  • Newtyn Management added most to Ardagh Metal Packaging in Q2 2022, an estimated $25.5M increase.
  • Newtyn Management's biggest Q2 2022 reduction was RLJ Lodging Trust $1.95 Series A Preferred Stock, cutting an estimated $6.69M.
  • Newtyn Management fully exited Loyalty Ventures Inc. Common Stock in Q2 2022, selling an estimated $9.48M.
  • Newtyn Management's ten largest holdings make up 51% of its $528M portfolio in Q2 2022.
  • Newtyn Management opened 48 new positions and closed 3 in Q2 2022.
  • Newtyn Management's portfolio value rose 26% quarter-over-quarter to $528M.

Based on Newtyn Management's 13F filing for Q2 2022, filed 15 Aug 2022.